Fundraising Fox

ADRx

Thousand Oaks, US · Delaware corporation · 2 known investors

Structure-based small-molecule drug design targeting protein aggregation diseases.

Biotech

Founders & leadership

JT
James TreanorAlso a former CEO
GW
Gary WilcoxNamed on SEC filing
JF
John FrankNamed on SEC filing
MB
Madhavan BalachandranNamed on SEC filing

Investors · 2

MRL Ventures FundCambridge · $25M
RA CapitalreportedBostonvia Reza Halse · board

Reported raises · per SEC filings

Form D private placements

$18.1M disclosed across 4 rounds · 2013–2020

▶$6MraisedDec 2020 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Reza HalseDirector
  • Gary WilcoxDirector
  • Madhavan BalachandranDirector
  • Marcin ApostolExecutive Officer
  • John FrankDirector
  • James TreanorDirector
Offering amount
$6M
Amount sold
$6M
Minimum investment
$60K
Proceeds to insiders
$300K
First sale
Dec 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4MraisedOct 2020 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Gary WilcoxDirector
  • James TreanorDirector
  • John FrankDirector
  • Madhavan BalachandranExecutive Officer, Director
Offering amount
$5.4M
Amount sold
$4M
Minimum investment
$16.5K
Proceeds to insiders
$250K
First sale
Nov 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.6MraisedOct 2020 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Doug LaneExecutive Officer
  • Gary WilcoxDirector
  • John FrankDirector
  • Madhavan BalachandranExecutive Officer, Director
  • James TreanorDirector
Offering amount
$2.6M
Amount sold
$2.6M
Minimum investment
$25K
Proceeds to insiders
$360K
First sale
Sep 2013
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.6MraisedOct 2020 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Gary WilcoxDirector
  • James TreanorDirector
  • John FrankDirector
  • Madhavan BalachandranExecutive Officer, Director
Offering amount
$5.6M
Amount sold
$5.6M
Minimum investment
$25K
Proceeds to insiders
$412K
First sale
Apr 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does ADRx do?
Structure-based small-molecule drug design targeting protein aggregation diseases.
Who are ADRx's investors?
ADRx's investors include MRL Ventures Fund, RA Capital.
How much funding has ADRx raised?
ADRx has disclosed $18.1M raised across 4 rounds.
Where is ADRx headquartered?
ADRx is headquartered in Thousand Oaks, US.